Medical Tech Startup Varinos Secures Approx. 1.25 Billion Yen in Series D Funding

Varinos Inc., a developer of genetic testing solutions using genomic technology, has completed a Series D funding round totaling approximately 1.25 billion yen through equity and debt financing. Led by Mirai Creation Investments, the round included new investors such as Mitsui Chemicals and Yokohama Capital. Alongside the funding, Varinos revamped its management team, appointing Hidetoshi Hirakawa as President. The new capital will be used to enhance the quality of its flagship 'Endometrial Flora Test,' accelerate domestic and international market expansion, and develop new healthcare services for women in collaboration with Mitsui Chemicals.